Početna › T-stanični limfom › Florida
Kliničke studije za T-stanični limfom u državi Florida
8 studija za T-stanični limfom traži sudionike na lokacijama u državi Florida.
Gradovi u državi Florida
Službeni tekst studije (engleski)
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT04803201Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
- Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine, Miami
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06561048Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
- Mayo Clinic in Florida, Jacksonville
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- i još 1
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT06724237CD4CAR for CD4+ Leukemia and Lymphoma
- University of Miami Sylvester Comprehensive Cancer Center, Miami
U tijeku regrutacijaFaza 1
Od 12 godina i više · Oba spola · Ažurirano 24. lip 2026. · NCT03829540A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
- Florida Cancer Specialists, Sarasota
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 16. lip 2026. · NCT05463263A Registry for People With T-cell Lymphoma
- University of Miami (Data Collection Only), Miami
- Moffitt Cancer Center (Data Collection Only), Tampa
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 20. svi 2026. · NCT05978141MB-105 in Patients With CD5 Positive T-cell Lymphoma
- Moffitt Cancer Center Magnolia Campus, Tampa
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 3. lis 2025. · NCT06534060Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- University of Miami, Miami
U tijeku regrutacijaFaza 1
Od 1 do 21 godina · Oba spola · Ažurirano 6. pro 2024. · NCT05476770Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.